Sharechat Logo

Australia’s Evolution Healthcare pays premium to buy stake in rival Acurity Health

Friday 25th October 2013

Text too small?

Evolution Healthcare, the Australian private equity healthcare company which owns Boulcott Hospital in Lower Hutt, is buying shares in Acurity Health which owns rival Wakefield Hospital.

Shares in private hospital group Acurity Health jumped 36 percent to an 11-month high as about 3.8 percent of the stock changed hands at $5.50.

Evolution Healthcare "is obviously trying to buy a large stake in Acurity Health," said Bryon Burke, head of equities at Craigs Investment Partners. Burke said Evolution was paying a premium to get volume although he didn't know how big a stake was being sought.

Evolution also owns Shellharbour Private Hospital, South Coast Private and Canberra Private Hospital, according to the company's website. Managing director Ben Thynne wasn't immediately available for comment.

NOTE: please be advised to read full articles from Business Desk Website, you will have to pay a subscription fee on their website.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Pushpay buys Colorado rival for US$87.5m
Xero chair to retire early as family’s health comes first
Business leaders quiz finance minister on capacity to spend $12b
House prices are accelerating again, even in Auckland
13th December 2019 Morning Report
Tourists still coming but growth is slowing
Peters backs StuffME merger bid
Supplements, skincare firm poised for reverse listing
NZX, EEX eye carbon auction opportunity
A2 Milk boss steps down, shares fall 7.7%

IRG See IRG research reports